Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life

Abstract

Sustained-release fampridine (fampridine-SR) improves gait velocity and self-perceived capacities in people with multiple sclerosis (MS). However, little is known about the treatment’s effect on temporospatial gait parameters, walking endurance, general fatigue, hand function and quality of life (QoL). We therefore sought to evaluate these parameters in a… (More)
DOI: 10.1007/s00415-015-7797-1

8 Figures and Tables

Topics

  • Presentations referencing similar topics